By Research and Markets (http://www.researchandmarkets.com/research/dh7zd9/global_rheumatoid) has announced the addition of the "Global Rheumatoid Arthritis Pipeline Highlights - 2014" report to their offering.
The latest report Rheumatoid Arthritis Pipeline Highlights - 2014, provides most up-to-date information on key pipeline molecules in the global rheumatoid arthritis market. It covers emerging therapies for rheumatoid arthritis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides rheumatoid arthritis pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides rheumatoid arthritis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides rheumatoid arthritis pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which rheumatoid arthritis pipeline products will be launched in the US and Ex-US till 2017.
Summary:
- Rheumatoid Arthritis phase 3 clinical trial pipeline molecules
- Rheumatoid Arthritis phase 2 clinical trial pipeline molecules
- Rheumatoid Arthritis phase 1 clinical trial pipeline molecules
- Rheumatoid Arthritis preclinical research pipeline molecules
- Rheumatoid Arthritis discovery stage pipeline molecules
- Rheumatoid Arthritis pipeline molecules short-term launch highlights
Key Topics Covered:
1. Rheumatoid Arthritis Pipeline by Stages
2. Rheumatoid Arthritis Pipeline by Drug Class
3. Rheumatoid Arthritis Pipeline by Company
4. Rheumatoid Arthritis Phase 3 Clinical Trial Insights
5. Rheumatoid Arthritis Phase 2 Clinical Trial Insights
6. Rheumatoid Arthritis Phase 1 Clinical Trial Insights
7. Rheumatoid Arthritis Preclinical Research Insights
8. Rheumatoid Arthritis Discovery Stage Insights
9. Appendix
10. Research Methodology
Tables
For more information visit http://www.researchandmarkets.com/research/dh7zd9/global_rheumatoid
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
